Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX)

Historical Holders from Q3 2021 to Q3 2025

Symbol
IMRX on Nasdaq
CUSIP
45254E107
Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Shares outstanding
58.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
26.1M
Holdings value
$182M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
69
Number of buys
54
Number of sells
-10
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 14.5% $71.5M 8.79M FMR LLC Sep 30, 2025
Empery Asset Management, LP 8.83% $36.3M 5.19M Empery Asset Management, LP Sep 30, 2025
Zeskind Benjamin J. 12.8% $5.13M 3.98M BENJAMIN J. ZESKIND Dec 31, 2024
HBM Healthcare Investments (Cayman) Ltd. 5.7% $29.7M 3.65M HBM Healthcare Investments (Cayman) Ltd. Sep 26, 2025

Institutional Holders of Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 26.1M $182M +$152M $7.00 69
2025 Q2 3.83M $12.9M -$685K $3.37 39
2025 Q1 4.5M $6.84M +$161K $1.52 34
2024 Q4 4.24M $9.32M -$179K $2.20 41
2024 Q3 4.36M $10.9M -$7.53M $2.49 38
2024 Q2 9.59M $12.3M -$9.13M $1.28 56
2024 Q1 11.9M $34.3M -$12.6M $2.89 50
2023 Q4 16.1M $119M -$6.3M $7.35 52
2023 Q3 16.9M $130M -$5.08M $7.68 51
2023 Q2 17.3M $176M +$56M $10.14 48
2023 Q1 11.8M $115M +$3.89M $9.71 33
2022 Q4 11.7M $56.9M -$4.4M $4.85 32
2022 Q3 12.1M $172M -$5.23M $14.32 30
2022 Q2 12.1M $65.6M -$8.96M $5.41 31
2022 Q1 13.6M $88.1M -$3.34M $6.47 48
2021 Q4 12.5M $200M +$5.45M $16.17 36
2021 Q3 12.1M $316M +$316M $26.55 38